Early dual antiplatelet therapy shows superior efficacy in reducing stroke recurrence compared with aspirin monotherapy.
Barcelona, Spain-A new analysis from the Early Use of Existing Preventive Strategies for Stroke (EXPRESS) study confirms that early aggressive treatment of patients with transient ischemic attack (TIA ...
Asundexian reduced ischemic stroke risk without increasing major bleeding in the OCEANIC-STROKE study, meeting primary efficacy and safety endpoints. The study included 12,327 patients with acute ...
Recent research findings suggest that people who have a transient ischemic attack (TIA) should get aggressive treatment to help prevent cognitive decline. A transient ischemic attack (TIA), also known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results